What Sirio Europe does

Sirio Europe GmbH & Co. KG is a Germany-based contract development and manufacturing organization (CDMO) specializing in advanced nutraceutical dosage forms for global brand customers. Founded in 1992 and headquartered in Pritzwalk with commercial offices in Frankfurt am Main and Barcelona, the company operates as the European arm of a larger SIRIO group that also runs two manufacturing industrial parks in China (Shantou and Ma'anshan). Sirio Europe manufactures softgels, gummies, hard capsules, tablets, and powders for nutraceutical, dietary supplement, and pharmaceutical clients under a B2B contract services model.

The company's competitive positioning rests on a proprietary portfolio of patented delivery formats, including Plantegrity® (a plant-based softgel technology with four variants including EnteriClear® enteric shell), LifeChews™ (clinically validated chewable jelly tablets delivering 198% bioavailability improvement vs. control for DHA), FizzyBits™ (instant-dissolve fizz tablets), XtraGummies™ (high-strength gummies supporting up to 1.5g creatine per unit), and Snowmelt™ (direct-to-mouth powder). These formats are bundled into category-driven concept platforms — most recently the Aeion™ longevity platform launched at Vitafoods Europe 2026 with eight ready-to-launch concepts — targeting beauty, sport, hydration, magnesium, women's health, and longevity. Sirio Europe holds an unusually broad stack of international certifications (FDA, GMP for production/packaging/warehouse, BRCGS, IFS, Friend of the Sea, MSC Chain of Custody, Organic) and achieved EcoVadis Silver Medal status in 2025 across both Chinese facilities, placing it in the top 15% of assessed companies globally.

Revenue is generated through three primary streams: CDMO manufacturing services (multi-year formulation, production, and packaging contracts under client brand specifications), private-label supply of pre-developed ready-to-launch concepts, and licensing of patented delivery technologies. Sales are conducted through direct enterprise engagement, supported by industry events (Vitafoods Europe, CPHI), downloadable catalogue resources, content marketing, and a "Start a Consultation" lead capture mechanism. Customer evidence is concentrated among European nutraceutical brands, with named clients including Royal Herkel and Omnivision GmbH. No public pricing is disclosed; quoting occurs through consultation.

Name

Sirio Europe

Legal name

Sirio Europe GmbH & Co. KG

Website

https://sirio-europe.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Sirio Europe is a Germany-headquartered CDMO that develops and manufactures innovative nutraceutical dosage forms — including plant-based softgels, jelly tablets, gummies, and instant-dissolve formats — for global supplement and pharmaceutical brands under proprietary patented technologies.

Ownership category

akta.pro rank

Product category

Nutraceutical CDMO (Contract Development & Manufacturing)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Nutraceutical CDMO services
• Contract manufacturing supplements
• Softgel manufacturing
• Nutraceutical delivery formats
• Private label supplements

Headquarters

HQ city

Pritzwalk

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. CDMO Manufacturing Services: SIRIO Europe operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end development and manufacturing services to nutraceutical brands. Revenue is generated through manufacturing fees for softgels, gummies, capsules, tablets, and powders produced under client brand specifications. Services include formulation development, manufacturing, quality control, and packaging — typically structured as multi-year manufacturing contracts with brand partners.
2. Private Label / Ready-to-Launch Concepts: SIRIO develops and offers pre-developed, ready-to-launch concept formulations across platforms (longevity, beauty, sport, hydration, women's health, magnesium) that brands can private-label. This enables faster time-to-market for brand clients, with stability studies and proven shelf life already validated. Revenue is generated through product supply agreements with brand partners adopting these concepts.
3. Technology Licensing / Patented Format Licensing: SIRIO licenses its proprietary delivery technologies (Plantegrity® plant-based softgel, LifeChews™ jelly tablets) to brand partners seeking differentiated formats. The patented nature of technologies like LifeChews™ creates licensing revenue opportunities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Sirio Europe is a Contract Development and Manufacturing Organization (CDMO) providing end-to-end development, manufacturing, quality control, and packaging services for nutraceutical and dietary supplement brands. Its core offering is the production of dosage forms — including softgels (both traditional gelatin and plant-based Plantegrity®), gummies (XtraGummies™), hard capsules, tablets, and novel formats such as LifeChews™ jelly tablets, FizzyBits™ instant fizz tablets, and Snowmelt™ direct-to-mouth powders — supported by formulation R&D and proprietary patented delivery technologies licensed to or co-developed with brand partners.

Product overview

Sirio Europe is a Contract Development and Manufacturing Organization (CDMO) providing end-to-end development and manufacturing services for nutraceuticals and dietary supplements. The company's product portfolio centers on innovative delivery formats organized around multiple platforms: XtraGummies™ for high-strength gummies; Plantegrity® for plant-based softgel technology; LifeChews™ for plant-based jelly tablets; FizzyBits™ for instant fizz tablets; Aeion™ for longevity-focused supplements; X Mg for magnesium products; and HydraPearls™ for hydration support via softgels. These are complemented by standard hard capsules, powders, and tablets. The offering integrates R&D, manufacturing, quality control, and packaging services supporting brands from concept through commercial production.

Differentiator

Problem solved

Functional benefit

Brands

• Plantegrity: Patented plant-based softgel technology offering temperature resistance, clean labeling, and environmental friendliness with four variants including carrageenan/corn starch shell, EnteriClear enteric shell, chewable shell, and gellan gum/corn starch shell.
• LifeChews
• FizzyBits
• XtraGummies
• Aeion

Products and services

• CDMO Manufacturing Services (End-to-end) End-to-end contract development and manufacturing organization (CDMO) service integrating R&D, manufacturing, quality, and packaging for nutraceutical brand partners across softgel, gummy, capsule, tablet, and powder dosage forms.
• Plantegrity® Plant-Based Softgel Technology Patented plant-based softgel capsule technology offering clean-label, vegan-friendly softgels with temperature resistance and stable shelf-life. Four variants: Carrageenan & Corn Starch Shell, EnteriClear® Enteric Vegan Shell, Chewable Shell, and Gellan Gum & Corn Starch Shell. Designed for nutraceutical brand partners seeking differentiated, plant-based delivery formats.
• LifeChews™ Plant-Based Jelly Tablet Format Patented plant-based chewable jelly tablet format for delivering lipid-soluble nutrients, clinically proven to improve bioavailability (161% higher blood plasma DHA vs. control, 198% bioavailability improvement). Each tablet can carry up to 250mg DHA without fishy taste or aftertaste. Targeted at nutraceutical brand partners seeking a differentiated, plant-based, high-bioavailability delivery format.
• FizzyBits™ Instant Fizz Tablet Format Instant-dissolve fizz tablet delivery format designed for portability and convenience — no water required at point of consumption. Includes product variants for energy support (B-complex vitamins), recovery (electrolytes and vitamin C), and cognitive support, with sugar-free and vegan-friendly options. Targeted at nutraceutical brand partners in the on-the-go supplement category.
• XtraGummies™ High-Strength Gummy Technology High-strength gummy delivery format capable of incorporating up to 1.5g of creatine per gummy without compromising taste, convenience, bioavailability, or stability. Supported by third-party stability studies. Designed for nutraceutical and sport-nutrition brand partners requiring high-dose active ingredients in a gummy format.
• Aeion™ Longevity Platform Pre-developed longevity supplement concept platform comprising eight ready-to-launch concepts developed in collaboration with the SIRIO Institute on Ageing, spanning gummies, softgels, direct-to-mouth powders, FizzyBits™, and LifeChews™ formats. Targeted at health and wellness brand partners entering the longevity category (energy, inflammaging, mobility, heart health, metabolism, skin health, mental energy).
• Snowmelt™ Instant-Dissolve DTM Powder Format Instant-dissolve direct-to-mouth (DTM) powder format that dissolves immediately on the tongue with no water required, designed for fast and easy consumption. Featured within the Aeion™ NAD+ Energy concept, pairing NADH with L-ergothioneine and vitamin C for mitochondrial function support. Available to nutraceutical brand partners as a differentiated delivery format.
• X Mg Magnesium Platform High-strength magnesium supplement concept platform offering gummies, distinctive softgel formulations combining three magnesium sources, and FizzyBits™ formats designed to support muscle health, sleep, relaxation, bone health, and immune support. Targeted at nutraceutical brand partners entering the differentiated magnesium category.
• Softgel Manufacturing (Gelatin and Plant-Based) Softgel capsule contract manufacturing services covering traditional gelatin softgels and plant-based Plantegrity® technology for nutraceutical and pharmaceutical applications. Supports simple multivitamin formulations through complex specialized solutions for menopause, eye health, and other targeted applications.
• Hard Capsules, Powders and Tablets Manufacturing Contract manufacturing of standard and customized hard capsules, powder formulations, and tablet products for pharmaceutical, nutraceutical, and health industries. Supports effervescent, chewable, double-layer, and coated tablet formats via automated production lines.
• Private Label / Ready-to-Launch Concepts Pre-developed ready-to-launch concept formulations across platforms (longevity, beauty, sport, hydration, women's health, magnesium) with validated stability studies and shelf-life data, available to brand partners for private-label adoption to accelerate time-to-market.

Quantifiable outcome

• 198% improvement in bioavailability for LifeChews™ vs. control (161% higher blood plasma DHA concentration)
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• SIRIO Institute on AgeingcoreStrategic or Co-development PartnerThe Aeion™ longevity platform was developed in collaboration with the SIRIO Institute on Ageing, which brings together renowned longevity researchers and leading ingredient partners. The institute provides scientific validation and research expertise supporting the formulation of the Aeion™ platform concepts.
• United Nations Global CompactcoreStrategic or Co-development PartnerSIRIO is a proud member of the United Nations Global Compact, anchoring its sustainability strategy in the vision of 'Healthy Products, A Healthy Supply Chain, and A Healthy Society.' This membership commits SIRIO to aligning operations with UN GC principles across human rights, labour, environment, and anti-corruption.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aenova Group: German-headquartered CDMO with a strong softgel, capsule, and tablet manufacturing portfolio serving pharma and nutraceutical brands across Europe. Directly comparable to SIRIO Europe in scale, geography, and core CDMO offering.
• Adare Pharma Solutions: US-headquartered CDMO specializing in oral solid dose forms including softgels, capsules, and tablets for pharma and consumer health. Comparable to SIRIO Europe in CDMO business model and target customer segments.
• NutraScience Labs: US-based contract manufacturer focused on dietary supplements in capsules, tablets, softgels, and gummies. Directly comparable in serving nutraceutical brands with outsourced manufacturing, although with smaller scale than SIRIO Europe.
• Best Formulations: US-based contract manufacturer of vitamins, supplements, and personal care products in softgels, tablets, capsules, and gummies. Comparable to SIRIO Europe in CDMO business model and nutraceutical brand customer focus.

Broad incumbents

• Catalent: Large global CDMO with broad softgel and oral dose capabilities including the former Accucaps/PG Softgelsoft acquisitions. Serves nutraceutical and pharma brand customers with a much wider portfolio than SIRIO but overlapping in softgels and oral dosage forms.
• Recipharm: European-headquartered CDMO offering softgel, tablet, capsule, and topical manufacturing services to pharmaceutical and consumer health brands. Overlaps with SIRIO Europe in oral solid dose CDMO services and European customer base.
• Eurofins CDMO: CDMO arm of Eurofins Scientific offering contract development and manufacturing for pharma, nutraceutical, and consumer health customers. Comparable in offering breadth and European customer overlap with SIRIO Europe.
• Procaps Group: Latin American-headquartered integrated CDMO and pharma company offering softgel, capsule, and other oral dose manufacturing to global nutraceutical and pharmaceutical customers. Comparable in CDMO scale and softgel technology emphasis.

Others

• Sirio Pharma (parent group, China): Parent operating group of SIRIO Europe with manufacturing and R&D operations in China. Directly related corporate parent rather than a true market peer, but operates the same CDMO business model across Asia and shares the same technology platforms.

Regional players

• Hermes Arzneimittel: German pharmaceutical and nutraceutical manufacturer with contract manufacturing capabilities. Comparable to SIRIO Europe as a German-headquartered CDMO serving the European consumer health market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ayanda-

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sirio Europe